This form is completed for recipients whose primary disease, reported on the Disease Classification (2402) Form, is Hodgkin Lymphoma (HL) or non-Hodgkin Lymphoma (NHL). One exception is Waldenstrom’s macroglobulinemia / lymphoplasmacytic lymphoma, for which, a Waldenstrom’s Macroglobulinemia (2019) Form will be completed instead.
Links to sections of form:
Subsequent Transplant or Cellular Therapy
Q1-55: Disease Assessment at Diagnosis
Q56-68: Laboratory Studies at Diagnosis
Q69-81: Assessment of Nodal and Organ Involvement at Diagnosis
Q82-139: Disease Assessment at Transformation
Q140-152: Laboratory Studies at Transformation
Q153-165: Assessment of Nodal and Organ Involvement at Transformation
Q166-223: Pre-HCT or Pre-Infusion Therapy
Q224-233: Disease Assessment at the Failure of the 1st Line of Therapy
Q234-288: Disease Assessment at the Last Evaluation Prior to the Start of the Preparative Regimen / Infusion
Manual Updates:
Sections of the Forms Instruction Manual are frequently updated. The most recent updates to the manual can be found below. For additional information, select the manual section and review the updated text.
To review the historical Manual Change History for this form, reference the retired manual section on the Retired Forms Manuals webpage.
| Date | Manual Section | Add/Remove/Modify | Description |
|---|---|---|---|
| 12/12/2025 | 2018: LYM Pre-Infusion | Modify | Version 6 of the 2018: Lymphoma Pre-Infusion Data section of the Forms Instruction Manual released. Version 6 corresponds to revision 7 of the Form 2018. |
Need more help with this?
Don’t hesitate to contact us here.